Biogen, Inc. (BIIB)
195.77
+3.74
(+1.95%)
USD |
NASDAQ |
Feb 23, 14:07
Biogen Price : 195.77 for Feb. 23, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1049.25 |
| Merck & Co., Inc. | 123.45 |
| AbbVie, Inc. | 227.84 |
| Pfizer Inc. | 27.02 |
| Stoke Therapeutics, Inc. | 36.71 |
Price Related Metrics
| PE Ratio | 22.23 |
| PS Ratio | 3.014 |
| Price to Book Value | 1.574 |
| Price to Free Cash Flow | 14.59 |
| Earnings Yield | 4.50% |
| Market Cap | 28.73B |
| Operating PE Ratio | 11.87 |
| Normalized PE Ratio | 16.79 |